Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1%

Similar documents
Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport

Institutional Equities

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

Institutional Equities

CARE Ratings. Institutional Equities. 2QFY18 Result Update BUY

3,746 2,551 3, NIM

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely

Institutional Equities

Bajaj Electricals. Institutional Equities. 3QFY15 Result Update

Institutional Equities

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

La Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536

Gillette India. Institutional Equities. 1QFY18 Result Update

Colgate-Palmolive (India)

93,707 77,814 90, NIM

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017

Cadila Healthcare. Institutional Equities. 3QFY15 Result Update UNDER REVIEW. Stable Performance. Sector: Pharmaceuticals CMP: Rs1,514

E&P To Stay Strong; Consumer Segment To Revive

Bata India. Institutional Equities. 1QFY19 Result Update BUY

La Opala RG. Institutional Equities. 1QFY18 Result Update

Atul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017

Jamna Auto Industries

Institutional Equities

Swiss Glascoat Equipments

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

EBITDA 5,019 4,211 5, EBITDA

9,807 8,007 9, NIM

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

9,251 7,812 8, NIM

Dalmia Bharat Enterprises

Punjab National Bank

Indian Oil Corporation

Punjab National Bank

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY

EBITDA 5,076 3, , EBITDA

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY

Punjab National Bank

Sun Pharmaceutical Industries

V-Guard Industries. Institutional Equities. Conference-call Update BUY. Sector: White Goods CMP: Rs914 Target Price: Rs1,109 Upside: 21%

Voltas. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Capital Goods CMP: Rs309 Target Price: Rs325 Upside: 5% 23 December 2016

Institutional Equities

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN

KEC International. Institutional Equities. Management Meet Update BUY. On Course Towards Recovery In Operating Margin

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN

Institutional Equities

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update

Institutional Equities

State Bank of India. Institutional Equities. 1QFY18 Result Update

Indian Oil Corporation

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL

Dabur India. Institutional Equities. 1QFY19 Result Update

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE

Bata India. Institutional Equities. Management Meet Update. Likely Getting Into A Virtuous Cycle BUY

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA

Institutional Equities

Institutional Equities

Arvind. Institutional Equities. Event Update BUY

KEC International. Institutional Equities. Management Meet Update. Healthy Order Inflow Traction Expected To Continue BUY

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY

EBITDA 6,223 6,511 (4.4) 5, EBITDA

JBF Industries. Institutional Equities. 1QFY16 Result Update BUY. Healthy Gross Profit Growth, But Other Costs Higher; Retain Buy

The Ramco Cements. Institutional Equities. Event Update BUY

IFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY.

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

FY11 FY12 FY13E FY14E

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY

TD Power Systems. Institutional Equities. Company Update BUY

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE

Punjab National Bank

Punjab National Bank

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018

Hindustan Unilever. Institutional Equities. 3QFY18 Result Update BUY

Persistent Systems. Institutional Equities. Management Meet Update SELL. Watson IOT Bet Risk/Reward More Muted Than Anticipated

Whirlpool of India. Institutional Equities. Analyst Meet Update. Aims To Sustain Strong Growth Trajectory; Retain Buy BUY

EBITDA 1,585 1,917 (17.3) 1,673 (5.2) EBITDA

Dalmia Bharat Enterprises

Apar Industries. Institutional Equities. Management Meet Update. In Turnaround Mode; Retain Buy BUY

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

Hindustan Unilever. Institutional Equities. Company Update. Faster And Stronger BUY. Sector: FMCG CMP: Rs1,350 Target Price: Rs1,570 Upside: 16%

Hindustan Unilever. Institutional Equities. 2QFY19 Result Update

Tech Mahindra. Institutional Equities. Company Interaction & Event Update SELL

Dalmia Bharat Enterprises

Huhtamaki PPL. Institutional Equities. Management Meet Update NOT RATED. CMP: Rs186 Sector: Packaging. 16 September 2014

2,09,057 1,85,859 2,17, (4.1) NIM

Sequent Scientific. Institutional Equities. 1QFY19 Result Update BUY

Manappuram Finance. Institutional Equities. 3QFY18 Result Update. The Glitter Is Back In Gold Loans BUY. 9 February 2018

Tata Consultancy Services

Institutional Equities

Relaxo Footwear. Institutional Equities. Management Meet Update NOT RATED. Sector: Footwear CMP: Rs December 2013

Bharat Financial Inclusion

Bharat Heavy Electricals

Transcription:

Management Meet Update Bata India Reuters: BATA.BO; Bloomberg: BATA IN On Right Track We had a meeting recently with Mr. R. K. Gupta, Chief Financial Officer (CFO) of Bata India (BIL) to understand recent developments in the company s business. The CFO was upbeat about BIL s future prospects and expects it to register double-digit volume growth with improvement in margins on YoY basis. New management at the helm: Mr. Sandeep Kataria has been appointed as Country Manager for the Indian sub-continent with effect from 1 August 17. Prior to his appointment at BIL, Mr. Kataria was Chief Commercial Officer at Vodafone India. He reports directly to Mr. Rajeev Gopalkrishnan who has been elevated as President - Asia South, based in Singapore, with a broader perimeter encompassing India, Bangladesh, Sri Lanka, Indonesia, Australia and New Zealand. We believe this is a positive change and should bring in fresh ideas on the table which will help the Bata brand to further strengthen across India. Strong push for new products: BIL has invested heavily in its Power brand last year and has refreshed it completely. Sales under Power brand increased from ~% to ~% in the past couple of years. The company launched Power XoRise Phantom (Actual Selling Price or ASP Rs3,5/pair) in FY17. Our channel check affirms that Phantom has been doing exceptionally well across major cities. Feedback received from the customers has been good so far. At the beginning of FY1, BIL had launched international styles for women such as Espadrilles and Bata Insolia range. BIL added SKUs since January 17, taking the total SKU count to 5,. Improvement in operating margin likely: The management sounded confident and expects improvement in margins on YoY basis. Improvement in margins is mainly expected on account of operating leverage because of better volume growth and a change in product mix. ASP at company level for BIL stood at ~Rs9/pair in FY17. ASP at BIL s 35 flagship stores (3, sqft) is ~Rs9/pair while at family stores (, sq.ft.) it is ~Rs/pair. Growth at BIL s flagship stores has been outpacing the growth at family stores (reverse trend). Better contribution from flagship stores should also help improve margins. We expect bps operating margin improvement over FY17-FY19E to 13.5%. Impact of Goods and Services Tax or GST to be neutral: The management believes that GST will be neutral for the company. Wholesale business (~% of total sales) has been impacted from GST and is yet to witness a recovery. BIL had received an order from Tamil Nadu government for supply of mn pairs of slippers (ASP Rs1/pair) in FY17. BIL has not received repeat order this year. However, BIL s retail business (~% of total sales) has been fairly shielded from any adverse impact of GST. For BIL, some states such as Delhi and Haryana have been losers while a state like Maharashtra has been positive despite GST implementation. Management commentary in line with our channel check: As per our channel check, there is more than 1% growth across cities. Store managers sounded very positive about growth prospects in FY1 and are expecting healthy demand during the festive season. High ASP products, mainly Hush Puppies and Power, are witnessing healthy traction across stores that we contacted. One of the most common feedbacks that we received from store managers has been that they are seeing a decent number of new products in women and sports segments. Most of the stores didn t witness any adverse impact on footfalls because of GST implementation. Valuation: Based on the feedback that we received from the management and the channel check, we have revised our estimates upward. We expect BIL s sales/ebitda/pat to post CAGR of 13%/%/%, respectively (earlier growth estimates are 11%/1%/1%, respectively). We expect margin improvement of bps over FY17-FY19E with EBITDA margin at.%/13.5% in FY1E/FY19E, respectively. We have valued the stock at 3x (3x earlier) FY19E earnings at Rs9 (earlier target Rs1) with an Accumulate rating. September 17 ACCUMULATE Sector: Retail CMP: Rs9 Target Price: 9 Upside: 1% Akhil Parekh Research Analyst akhil.parekh@nirmalbang.com +91--39 93 Sara Jaffer Research Associate sara.jaffer@nirmalbang.com +91--39-39 Key Data Current Shares O/S (mn).5 Mkt Cap (Rsbn/US$bn) 9./1. 5 Wk H / L (Rs) 7/399 Daily Vol. (3M NSE Avg.) 7,59 One Year Indexed Stock Performance 13 11 1 9 7 Sep-1 Nov-1 Jan-17 Mar-17 May-17 Jul-17 Sep-17 Price Performance BATA INDIA LTD Nifty 5 1 M M 1 Yr Bata India 9. 39.5. Nifty Index (.) 11. 11.1 Source: Bloomberg

1,79,35,7 3,1 3,39,75,7 3,9, Exhibit 1: Key financials Y/E Dec (Rsmn) FY15 (15M) FY1 FY17 FY1E FY19E Revenues,9,7,73 7,3 31,73 YoY...1.5. EBITDA 3,39,75,7 3,9, EBITDA. 11. 11.3. 13.5 Adjusted PAT, 1,53 1,77,,795 Reported PAT,3,19,3,,795 FDEPS (Rs).7 11.9 13. 17. 1. YoY -3. 17.3 15... RoE 19.9 19.7 1.1 1.3 17. RoCE 17.7.. 1.5 17.9 RoIC.. 5. 31.7 33. P/E (x) 5. 5. 5.1 39. 31. Price/sales (x).1 3.7 3. 3.. EV/EBITDA (x) 3. 3. 9.5 3.5 1.9 Exhibit : Sales growth (Rsmn) 35,. 5 19. 3,.1. 5, 15,.5 1. 5 15,.1 1, (5) 5, (1.1) (1) - (15) CY1 CY11 CY CY13 FY15 FY1 FY17 FY1E FY19E Net Sales Growth Exhibit : Gross Margins Exhibit 3: EBITDA growth (Rsmn),5 5, 37.3 3,5.5 3 3, 19.1 17.3 5.,5 1,.1 1,5 1. 1, (1) 5 (17.) () - (3) CY1 CY11 CY CY13 FY15 FY1 FY17 FY1E FY19E Exhibit 5: EBITDA Margins EBITDA Growth 5.5 5. 53.5 53. 5.5 5. 51.5 5.7 5.9 5.9 5.1 5.1 5.5 51.9 5. 5.5 1 1 1 13.3.9.9 15.. 11. 11.3. 13.5 51. 5.5 CY1 CY11 CY CY13 FY15 FY1 FY17 FY1E FY19E CY1 CY11 CY CY13 FY15 FY1 FY17 FY1E FY19E Bata India

1CY13 CY 1QFY1 QFY1 3QFY1 QFY1 QFY17 QFY17 1QFY1 1CY13 CY 1QFY1 QFY1 3QFY1 QFY1 QFY17 QFY17 1QFY1 Exhibit : Gross Margins Exhibit 7: EBITDAM Quarterly 5 5 5 5 5 5.1 51.9 5. 5.3 5. 5. 55. 5. 5.. 53. 51. 5.3 53. 51.5 53. 5.1 5.3 1 1 1 1. 1. 15. 13.9 13.1 13.3 11...5..5 13. 11. 1. 9.5.5 9. 9. Exhibit : PAT growth (Rsmn) 3, 7.3 5,5,..5 3 1,5 1.1. 15. 1 1,. (1) 5 (.9) () - (3) CY1 CY11 CY CY13 FY15 FY1 FY17 FY1E FY19E PAT Growth Exhibit 1: Return on Invested Capital (RoIC) 35 31.7 33. 3 5. 5.. 15 1 5 FY15 FY1 FY17 FY1E FY19E Exhibit 9: Return on Equity (RoE) 5 19.9 19.7 17. 1.1 1.3 15 1 5 FY15 FY1 FY17 FY1E FY19E Exhibit 11: Return on Capital Employed (RoCE) 17.7 17.9 1 1.5 1.. 1 FY15 FY1 FY17 FY1E FY19E 3 Bata India

Sep- 1CY13 Mar-9 Sep-9 Mar-1 Sep-1 Mar-11 Sep-11 Mar- Sep- CY Mar-13 Sep-13 Mar- 1QFY1 Sep- QFY1 Mar-15 3QFY1 Sep-15 QFY1 Mar-1 Sep-1 Mar-17 QFY17 Sep-17 Jan- 1CY13 Jun- Dec- May-9 Nov-9 Apr-1 Oct-1 Mar-11 Sep-11 Feb- CY Aug- Jan-13 Jul-13 1QFY1 Dec-13 Jun- QFY1 Nov- 3QFY1 May-15 Oct-15 QFY1 Apr-1 Sep-1 QFY17 Mar-17 Aug-17 Exhibit : Rental Exhibit 13: Employee expense Quarterly 1% 1% % % 1% % % % 13.% 1.9% 13.1% 13.%.% 11.7%.9% 13.5% 15.9%.3% 1.%.9% 13.% 15.%.1%.% 1 11. 9. 11. 9. 11. 9.9.9 11.9 11.9 9.7 11.5 9.7.5 11. 1. 1. % % Exhibit : 1-Yr forward P/E and P/B charts (Rs) 7 5 3 x 35x 3x 5x x 15x (Rs) 1, 1, x 7x x 5x x 1 Source: BSE, Nirmal Bang Research Source: BSE, Nirmal Bang Research Bata India

Financials Exhibit 15: Income statement Y/E March (Rsmn) FY15 (15m) FY1 FY17 FY1E FY19E Net Sales,9,7,73 7,3 31,73 % growth...1.5. Raw Material,37 11,51 11,51 13,53 15,7 Staff 3,119,15,73,99 3,113 Rent 3,73 3,7 3,5 3,731,19 Freight 9 55-557 35 Commission 7-35 95 Others,991,5, 3,3 3,91 Total Expenditure 3,591 1,9 1,957,39 7,5 EBITDA 3,39,75,7 3,9, % growth (1.) 3. 1. 5..5 EBITDA margin. 11. 11.3. 13.5 Other income 3 53 59 Interest 1 17 Depreciation 79 7 5 7 7 Profit Before Tax,971,19,555 3,31,9 % growth (1.) (.7) 15. 3..5 Tax 9 5 7 1,39 1,7 Effective tax rate 31. 3.9 3. 31.3 31.3 Adjusted Net Profit, 1,53 1,77,,795 % growth (17.9) (.) 15...5 Extraordinaries 35 5 - - Reported Net Profit,3,19,3,,795 % growth (3.) 17.3 (.7)..5 Exhibit 17: Balance sheet Y/E March (Rsmn) FY15 (15m) FY1 FY17 FY1E FY19E Equity 3 3 3 3 3 Reserves 9,579 11,19,1,15 1,5 Net worth 1,1,9 13,3,795 1,99 Short-term Loans - - - - - Long-term Loans - - - - - Total Loans - - - - - Deferred Tax Liability (7) (91) (1,) (1,) (1,) Liabilities 9,35 11,31, 13,791 15,95 Gross Block 7,5 7,7,57 9,99 1,99 Depreciation 3,3,71 5,31 5,991,73 Net Block 3,33 3,97,735 3,3 3,57 Capital work-in-progress 1 13 - - Long-term Investments 5 1,3 1,3 1,3 1,3 Inventories 7,7,5 7,13 7,,39 Debtors 5 71 9 773 Cash,1 3,5 5, 5,95,71 Other Current assets,19 5 57,7,539 Total Current assets 11,9 11,57 13,19 15,735 1,1 Creditors,55,315 5, 5,73 5,7 Other current liabilities 1, 1,1,3 Total current liabilities,153 5,1 5,9, 7,73 Net current assets 5,77,55 7,31,53 1,9 Total Assets 9,35 11,31, 13,791 15,95 Exhibit 1: Cash flow Y/E March (Rsmn) FY15 (15m) FY1 FY17 FY1E FY19E EBIT,557 1,97,135,5 3,5 (Inc.)/Dec in working capital (1,3) 17 (1,) (9) Cash flow from operations 1,333,5,755 1,77 3,7 Other income 3 53 59 Depreciation 79 7 5 7 7 Deffered Liabilities (195) (15) (113) - - Interest paid (-) (1) (17) () () () Tax paid (-) (9) (5) (7) (1,39) (1,7) Dividends paid (-) (9) (53) (5) (77) (9) Extraordinary Items 35 (5) - - Net cash from operations 1,19 3,17,99 1,,17 Capital expenditure (-) (1,1) (71) (39) (1,) (1,) Net cash after capex (5),5 1,73 1,17 Inc./(Dec.) in short-term borrowing - - - - - Inc./(dec.) in long-term borrowing - - - - - (Inc.)/Dec. in investments (1) (1,53) - - Cash from Financial Activities (1) (1,53) - - Others / Extraordinary income (11) 3 91 7 () Opening cash,557,1 3,5 5, 5,95 Closing cash,1 3,5 5, 5,95,71 Change in cash (5) 1,35 1,79 7 1,17 Exhibit 1: Key ratios Y/E March FY15 (15m) FY1 FY17 FY1E FY19E Per share (Rs) EPS.7 11.9 13. 17. 1. Book value 79.5 9.1 13. 115.1 9.9 Valuation (x) P/E 5. 5. 5.1 39. 31. P/sales.1 3.7 3. 3.. P/BV.7 7.5.7. 5.3 EV/EBITDA 3. 3. 9.5 3.5 1.9 EV/sales. 3.5 3.3.9.5 Return ratio RoIC.. 5. 31.7 33. RoCE 17.7.. 1.5 17.9 RoE 19.9 19.7 1.1 1.3 17. Margin ratio EBITDA margin. 11. 11.3. 13.5 PBIT margin 9.5.1. 1.1 11. PBT margin 11. 9. 1.3 11.9. PAT margin 7..3 7... Turnover ratio Asset turnover ratio (x).3.1... Avg inventory period (days) 13 115 117 11 11 Avg collection period (days) 1 11 1 1 1 Avg payment period (days) 7 7 75 75 Growth Sales...1.5. EBITDA (1.) 3. 1. 5..5 PAT (3.1) 17.3 (.7)..5 5 Bata India

Apr-1 May-1 Jun-1 Jul-1 Aug-1 Sep-1 Oct-1 Nov-1 Dec-1 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Rating track Date Rating Market price (Rs) Target price (Rs) April 1 Buy 15 57 1 May 1 Buy 59 1 August 1 Accumulate 5 59 3 November 1 Accumulate 55 7 February 17 Accumulate 759 7 1 May 17 Accumulate 57 3 August 17 Accumulate 5 1 September 17 Accumulate 9 9 Coverage shifted to Akhil Parekh since 7 Feb 17. Rating Track Graph 75 7 5 55 5 5 35 3 Not Covered Covered Bata India

Disclaimer Stock Ratings Absolute Returns BUY > 15% ACCUMULATE -5% to15% SELL < -5% This report is published by Nirmal Bang s Research desk. Nirmal Bang group has other business units with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. Reports based on technical and derivative analysis may not match with reports based on a company's fundamental analysis. This report is for the personal information of the authorised recipient and is not for public distribution. This should not be reproduced or redistributed to any other person or in any form. This report is for the general information for the clients of Nirmal Bang Equities Pvt. Ltd., a division of Nirmal Bang, and should not be construed as an offer or solicitation of an offer to buy/sell any securities. We have exercised due diligence in checking the correctness and authenticity of the information contained herein, so far as it relates to current and historical information, but do not guarantee its accuracy or completeness. The opinions expressed are our current opinions as of the date appearing in the material and may be subject to change from time to time without notice. Nirmal Bang or any persons connected with it do not accept any liability arising from the use of this document or the information contained therein. The recipients of this material should rely on their own judgment and take their own professional advice before acting on this information. Nirmal Bang or any of its connected persons including its directors or subsidiaries or associates or employees or agents shall not be in any way responsible for any loss or damage that may arise to any person/s from any inadvertent error in the information contained, views and opinions expressed in this publication. Nirmal Bang Equities Private Limited (hereinafter referred to as NBEPL ) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited. NBEPL has registered with SEBI as a Research Entity in terms of SEBI (Research Analyst) Regulations,. (Registration No: INH3-19..15 to 1..). NBEPL or its associates including its relatives/analyst do not hold any financial interest/beneficial ownership of more than 1% in the company covered by Analyst. NBEPL or its associates/analyst has not received any compensation from the company covered by Analyst during the past twelve months. NBEPL /analyst has not served as an officer, director or employee of company covered by Analyst and has not been engaged in market-making activity of the company covered by Analyst. The views expressed are based solely on information available publicly and believed to be true. Investors are advised to independently evaluate the market conditions/risks involved before making any investment decision. Access all our reports on Bloomberg, Thomson Reuters and Factset. Team Details: Name Email Id Direct Line Rahul Arora CEO rahul.arora@nirmalbang.com - Girish Pai Head of Research girish.pai@nirmalbang.com +91 39 17 / 1 Dealing Ravi Jagtiani Dealing Desk ravi.jagtiani@nirmalbang.com +91 39 3, +91 3 33 Pradeep Kasat Dealing Desk pradeep.kasat@nirmalbang.com +91 39 1/11, +91 3 31 Michael Pillai Dealing Desk michael.pillai@nirmalbang.com +91 39 /13, +91 3 3 Nirmal Bang Equities Pvt. Ltd. Correspondence Address B-, 31/3, Marathon Innova, Nr. Peninsula Corporate Park, Lower Parel (W), Mumbai-13. Board No. : 91 39 /1; Fax. : 39 1 7 Bata India